SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is facing significant downward pressure as investors react to a large-scale private exchange of convertible notes for equity, which is causing concerns over shareholder dilution. While some in the community view the debt reduction as a strategic move to clean up the balance sheet for potential future acquisitions, others are expressing frustration over the lack of immediate price performance and the ongoing dilution of their ownership stake.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending due to heightened volatility and community speculation ahead of their Q2 2026 earnings report, with investors closely watching the company's progress in scaling autonomous delivery fleets and expanding into healthcare partnerships. The community remains deeply divided, balancing excitement over potential short-squeeze dynamics and institutional backing against frustrations regarding prolonged share price weakness and ongoing concerns about cash burn.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investor optimism builds around Briumvi's market share expansion and the company's aggressive growth trajectory toward significant annual revenue milestones. The community is actively debating the likelihood of a strategic acquisition, fueled by analyst target raises and the company's robust pipeline development in autoimmune and neurology indications.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors digest the company's aggressive pivot toward AI infrastructure through its acquisition of Northern Data, a move that is fueling debate over its potential to reprice as an AI compute powerhouse rather than just a media platform. The stock is seeing intense community discussion surrounding its high short interest, which bulls view as a catalyst for a potential squeeze as they wait for formal financial guidance and upcoming earnings reports to validate the firm's significant GPU and power capacity investments.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors aggressively debate its valuation and fair market price relative to its underlying holdings in high-profile private AI companies like Anthropic and OpenAI. The community remains deeply divided, with bulls pointing to the potential IPO upside of its major assets, while bears argue the fund is drastically overvalued and trading at a significant premium to its actual net asset value.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is currently trending as investors focus on its strong fundamental revenue model, where a significant portion of platform fees are used for automated token buybacks and burns. The community is actively discussing its decoupling from broader crypto market volatility, the institutional interest driven by new investment vehicles, and its expanding utility in RWA and pre-IPO trading.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is trending as investors digest contradictory reports regarding U.S.-Iran negotiations, fueling intense debate between bullish traders banking on a market breakout and bears anticipating a liquidity rug pull. The community is heavily focused on technical levels and options gamma, with many debating whether the current rally is a sustainable squeeze or a temporary move based on geopolitical noise.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as a major market leader following a significant earnings beat and revenue growth acceleration that has shifted investor focus toward its AI infrastructure potential. The community is actively discussing the company's massive capital expenditure plans alongside its $496B cloud backlog, debating whether this spending cycle is a long-term profit catalyst or a short-term valuation risk.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging following news of a strategic partnership with Midjourney to power a new AI-driven full-body imaging scanner. While long-term investors are highlighting the company's semiconductor and AI-focused growth strategy, many in the community are debating the stock's high valuation and the high volume of insider selling as potential catalysts for a near-term correction.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing intense community speculation as investors wait for the Phase 3 IZAR-1 trial results, with sentiment heavily focused on whether management will deliver best-in-class data following previous guidance. While some participants are concerned by recent insider selling and price consolidation, many see the current levels as a tactical entry point, banking on the stock's potential for a significant re-rating driven by upcoming clinical readouts and the prospect of M&A activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRBU $VERV $LLY $PSTX Lilly watched Verve for two years after a $60M partnership before buying it for $1.3B. The playbook is the same. Pfizer invested $25M into Caribou in July 2023, took a board seat, and holds ROFN rights through July 2026. They have had full visibility into the data since day one. Caribou just delivered clean 12 month CRs and strong safety, the proof point Pfizer needed. The reverse split was canceled, burn is reduced, and cash covers the runway into 2026. Pfizer is not in a hurry. They are letting the setup ripen while maintaining control from the inside.

Roche did this exact same thing with Poseida. First came a collaboration, then a quiet year of watching data mature, followed by a full $1.5B acquisition once durability and safety were proven. Pfizer’s pattern with Caribou is identical, only with deeper access and longer visibility. Every move points to preparation, not survival. The structure, timing, and silence all signal a buyout in progress.

JG-JeRzeee

Steven B

travis Quinn

aragorn

Michael

Rob faron

Robert Glenn

Poppychulo931

gordon gecko

Ewak21

Joe Christenson

StockTwits for iOS

Caribou Biosciences Inc

Verve Therapeutics Inc

Lilly(Eli) & Co

Poseida Therapeutics Inc

 Lilly watched Verve for two years after a $60M partnership before buying it for $1.3B. The playbook is the same. Pfizer invested $25M into Caribou in July 2023, took a board seat, and holds ROFN rights through July 2026. They have had full visibility into the data since day one. Caribou just delivered clean 12 month CRs and strong safety, the proof point Pfizer needed. The reverse split was canceled, burn is reduced, and cash covers the runway into 2026. Pfizer is not in a hurry. They are letting the setup ripen while maintaining control from the inside.

Roche did this exact same thing with Poseida. First came a collaboration, then a quiet year of watching data mature, followed by a full $1.5B acquisition once durability and safety were proven. Pfizer’s pattern with Caribou is identical, only with deeper access and longer visibility. Every move points to preparation, not survival. The structure, timing, and silence all signal a buyout in progress.

LSTMLabs

@RocroBio either Tuesday or Wednesday I assume they will drop financials. This very well could be the real “catalyst” we thought we were getting last week.  Partnership/buyout 👀.

 either Tuesday or Wednesday I assume they will drop financials. This very well could be the real “catalyst” we thought we were getting last week.  Partnership/buyout 👀.

Jedediah Minyard

@RocroBio I think it’s important if Rachel want to sell or not.

Peterson

 I think it’s important if Rachel want to sell or not.

Jidane

@RocroBio you do good work 
- keep doing you

@RocroBio @josegodoy I agree I enjoy your posts..  very thoughtful logical, hopefully it comes true.

 I agree I enjoy your posts..  very thoughtful logical, hopefully it comes true.